A Phase III Multinational Multicenter Investigator-Masked Randomized Active-Controlled Trial Comparing the Efficacy and Safety of DE-130A With Xalatan® in Patients With Open-Angle Glaucoma or Ocular Hypertension

NCT04133311 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

386

Enrollment

INDUSTRY

Sponsor class

Conditions

Open-Angle Glaucoma or Ocular Hypertension
Ocular Surface Disease

Interventions

DRUG: DE-130A
DRUG: Xalatan®
DRUG: DE-130A/DE-130A
DRUG: Xalatan®/DE-130A

Sponsor

Santen SAS